HERMES (Recruiting)
Effects of ziltivekimab versus placebo on morbidity and mortality in patients with heart failure with preserved ejection fraction and systemic inflammation
- Medicine
- Ziltivekimab
- Population
- Heart failure
- Phase
- III
- Starting year
- 2022